Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Journal Articles

Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders

Timothy Schieber, Anthony Li, Jordan Lundberg, Tracy Wiczer, Timothy Voorhees

Blood Adv (2023) 7 (14): 3431–3434.

https://doi.org/10.1182/bloodadvances.2022009548

Published: 2023